Thyrocare sees fresh insider trade purchases by promoters
Healthtech firm Thyrocare (which is in 12 stock screeners) has seen fresh insider trade purchases by its promoters. Promoters bought 82,900 Thyrocare shares in mid Feb, and 10,000 shares today (26 April). The company's share price is near its year low, and technicals are weak. Share price fell after the company showed YoY negative net profit growth and EPS growth in the December quarter.
Thyrocare Technologies Ltd - 539871 - Shareholding for the Period Ended March 31, 2019
Thyrocare Technologies Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2019. For more details, kindly Click here Thyrocare Technologies Ltd - 539871 - Statement Of Investor Complaints For The Quarter Ended March 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0220 Name of the Signatory :- Ramjee DoraiDesignation :- Company Secretary and Compliance Officer Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are filing herewith a transcript of the conference call held on Tuesday, February 12, 2019 at 04.30 P.M. local time, to discuss the Company's unaudited financial results (Stand-alone and Consolidated) for Quarter / Nine Months ended December 31, 2018. Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you about the following Analyst Meetings which would take place at our Corporate Office. i) Meeting of the representative(s) of Consortium Securities Private Limited, at 3.30 P.M. on Friday, February 22, 2019. ii) Meeting of the representative(s) of Pragya Equities Private Limited, at 5.00 P.M. on Wednesday, February 27, 2019. Please note that the above shall be subject to changes, if any. Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you about the following Analyst Meetings which would take place at our Corporate Office. i) Meeting of the representative(s) of Ambit Capital Private Limited, at 4.00 P.M. on Wednesday, February 20, 2019. ii) Meeting of the representative(s) of InvesQ Equity Investment Advisor, at 11.00 A.M. on Thursday, February 21, 2019. iii) Meeting of the representative(s) of India Ratings & Research Private Limited, a Fitch Group Company, at 4.00 P.M. on Thursday, February 21, 2019. Please note that the above shall be subject to changes, if any. Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the representative(s) of SAIF Partners would be having a meeting with us at 1.00 P.M. on Friday, February 15, 2019 at the Corporate Office of the Company. Please note that the above shall be subject to changes, if any. Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the representatives of Kayne Anderson Rudnick Investment Management LLC, USA and Macquarie Capital Securities (India) Private Limited, would be having a meeting with us at 12.00 Noon on Thursday, February 14, 2019 at the Corporate Office of the Company. Please note that the above shall be subject to changes, if any. Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the representative(s) of SPARX Asset Management, would be having a one-to-one meeting with us at 2.30 P.M. on Tuesday, February 19, 2019 at the Corporate Office of the Company and would also visit our Central Processing Laboratory after the meeting. Please note that the above shall be subject to changes, if any. Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Investor Presentation
We are forwarding a copy of Presentation on Quarterly Results of our company for the quarter / nine months ended 31-12-2018. Please note that this is only uploaded in our website, and is not being distributed or advertised in newspapers or otherwise publicised.